Press Releases

Bethesda, Md., December 8, 2015 – The Parenteral Drug Association (PDA) announced the results of its Board of Directors election, including newly elected members to the Executive Committee.

Bethesda, Md., November 18, 2015 – The Parenteral Drug Association (PDA) has announced a change in leadership for its education programs.

Bethesda, Md., November 4, 2015 – The Parenteral Drug Association (PDA) is sponsoring its third conference on quality metrics Nov. 9-11 at the Bethesda North Marriott Hotel and Conference Center.

Bethesda, Md., October 27, 2015 – The Parenteral Drug Association (PDA) is once again hosting its Universe of Pre-Filled Syringes and Injection Devices conference in Europe. The November 3-4 event takes place in the Austria Center Vienna. This year, 103 vendors will be on hand to display their products and solutions for pharmaceutical companies looking to offer their products in these devices, which are rapidly becoming standard for injectable products.

Bethesda, Md., October 22, 2015 – In addition to the leading forum for visual inspection of parenteral products, the Parenteral Drug Association (PDA) is proud to offer the largest exhibition of commercial visual inspection hardware at the 2015 Visual Inspection Forum in Bethesda, Md., October 26-27.

Bethesda, Md., October 14, 2015 – The Parenteral Drug Association (PDA) is celebrating the tenth anniversary of its Annual Global Conference on Pharmaceutical Microbiology. This annual event brings together microbiologists throughout the industry and regulatory bodies to discuss the latest trends in microbial testing, sterilization technology, and other topics of interest to this scientific community.

Bethesda, Md., August 24, 2015 – The Parenteral Drug Association (PDA) today presented its perspective on the U.S. FDA’s draft Request for Quality Metrics Guidance for Industry at a public meeting at FDA’s White Oak Campus in Silver Spring, Md.

Bethesda, Md., July 27, 2015 – The Parenteral Drug Association (PDA) is teaming up with the Pharmaceutical Inspection Co-operation Scheme (PIC/S) to conduct training for pharmaceutical professionals in Hyderbad and Ahmedabad India on the International Conference on Harmonisation quality guideline Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients.

Bethesda, Md. June 29, 2015 - The Parenteral Drug Association is pleased to announce that the New Jersey Board of Professional Engineers and Land Surveyors has approved PDA Education as a provider of courses to professional engineers for continuing professional competency (CPC) credits.

Bethesda, Md., June 10, 2015 – Manufacturers of sterile drug products devote significant resources on programs to control microbial contamination in their products/processes. Bioburden and biofilm management is a significant aspect of microbial control strategies. Persistent bioburden and biofilm problems have been directly linked to several recalls and plant shutdowns.

Bethesda, Md., May 28, 2015 – The Parenteral Drug Association (PDA) proudly announces that it will be a supporting organization of the Johnson & Johnson Kilmer Conference on sterility assurance and sterilization in 2016.

Bethesda, Md., May 14, 2015 – The Parenteral Drug Association (PDA) today is pleased to announce that Robert Califf, MD, U.S. FDA Deputy Commissioner of the Office of Medical Products and Tobacco will deliver the keynote address at the 2015 PDA/FDA Joint Regulatory Conference, September 28-30, Washington, DC.

Bethesda, Md., May 6, 2015 – The Parenteral Drug Association (PDA) Board of Directors today announced that it has finalized agreement with Richard M. Johnson to continue as President and CEO through 2021.

Bethesda, Md., April 2, 2015 – PDA Education, part of the Parenteral Drug Association (PDA), announces the installation of new equipment in the Training and Research Institute (TRI) in Bethesda.

A press conference to provide updates on PDA’s Manufacturing Science ProgramSM, Aseptic Processing Points to Consider and other activities in 2015

Bethesda, Md., February 18, 2015 – The Parenteral Drug Association (PDA) today announced that it is releasing Technical Report No. 68: Risk-Based Approach for Prevention and Management of Drug Shortages (TR-68) to the public for free in an effort to reduce potential drug shortages caused by manufacturing quality issues.

NEW YORK, NY, BETHESDA, MD; January 20, 2015 – International Pharmaceutical Expo (INTERPHEX), the premier pharmaceutical and biopharmaceutical event dedicated to innovation, technology and knowledge, and its premier sponsor, Parenteral Drug Association (PDA), the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community, have partnered to bring to those involved in bio/pharmaceutical manufacturing unrivaled exposure to education, networking and technology.

BETHESDA, Md., January 22, 2015 – The Parenteral Drug Association (PDA) today announced the launch of its new Manufacturing Science ProgramSM: Enabling Pharmaceutical Manufacturing’s Future.